Antiestrogenic compounds inhibit estrogen induced expressions of basic fibroblast growth factor and its mRNA in well-differentiated endometrial cancer cells

Gen Pharmacol. 1998 Jul;31(1):169-70. doi: 10.1016/s0306-3623(97)00417-5.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Cell Differentiation / drug effects
  • Endometrial Neoplasms / drug therapy*
  • Endometrial Neoplasms / metabolism
  • Endometrial Neoplasms / pathology
  • Estrogen Antagonists / therapeutic use*
  • Female
  • Fibroblast Growth Factor 2 / biosynthesis*
  • Fibroblast Growth Factor 2 / genetics
  • Humans
  • RNA, Messenger / biosynthesis*

Substances

  • Estrogen Antagonists
  • RNA, Messenger
  • Fibroblast Growth Factor 2